ABSTRACT
O R I G I N A L P A P E R ultrasound diagnosis of ovarian cancer by non-expert operators of average ability and experience [1] [2] [3] . A number of previous original and validation studies showed that LR1 and LR2 perform well when used by expert operators and can facilitate preoperative differentiation between benign and malignant tumors in women undergoing surgical treatment for an adnexal tumor 1, 4 . Only a minority of women with an ultrasound diagnosis of an adnexal tumor, however, require surgery and, in routine clinical practice, the critical issue is not who will perform surgery (a general or an oncological surgeon), but whether any intervention is required at all. There have been no studies so far that have assessed the suitability of the IOTA models for the diagnosis of ovarian cancer in the outpatient setting and for prioritizing women with adnexal tumors for surgical intervention. The prevalence of malignancy in women attending outpatient clinics is likely to be lower compared with in women scheduled for surgery, which could result in a larger number of interventions in women with benign disease, even if the good diagnostic accuracy of IOTA models is maintained.
Another difficulty with using a test in the outpatient setting is that only a proportion of women would be selected for surgical treatment. Histological findings, which are traditionally used as the reference standard for assessing the accuracy of models for the diagnosis of ovarian cancer, are not applicable to a population of women managed conservatively. In such circumstances, a 'delayed type prospective cross-sectional study', which includes carefully planned and prolonged clinical follow-up, may provide the best evidence necessary to define the appropriate reference standard 5 . In the context of the diagnosis of ovarian cancer, it remains uncertain as to what are the required length of follow-up and the appropriate frequency of visits to determine the nature of an adnexal tumor.
In this prospective study, we assessed the accuracy of IOTA-LR1 and -LR2 models for the diagnosis of ovarian cancer in an outpatient setting using histology as the first reference standard and comparative assessment of tumor morphology on follow-up ultrasound scan as a second reference test. We also assessed the potential impact on intervention rates of a policy that would replace pattern recognition with the IOTA models for prioritizing for surgery women with adnexal tumors.
METHODS
This was a single-center prospective observational study of consecutive women attending our gynecological diagnostic unit for a variety of gynecological complaints. We also included women who were diagnosed with an ovarian cyst on previous imaging in a primary-care setting and who were referred to us for specialist gynecological imaging and management advice. The patients were recruited for the study between May 2009 and January 2012 and all women had completed follow-up by January 2014. During the initial recruitment visit, a detailed history was taken and women underwent clinical and ultrasound examinations. Women over the age of 40 who had had no period for 12 consecutive months with no other identifiable physiological, pathological or medical cause were defined as postmenopausal, and women over the age of 50 years who had undergone a hysterectomy were also classified as postmenopausal.
All ultrasound examinations were performed by N.N., who was a Level-II operator. She was trained in the use of the IOTA protocol but not in tumor pattern recognition 1, [6] [7] [8] [9] [10] . She was discouraged from attempting to provide a histological diagnosis or attempting to differentiate subjectively between benign and malignant tumors on ultrasound scan. Women with evidence of adnexal tumors on ultrasound scan were considered suitable for this study, but those with unilocular, anechoic cysts of mean diameter less than 2 cm were excluded. Pregnant women and those unable to undergo a transvaginal scan were also excluded from the final data analysis.
The probability of malignancy within an adnexal mass was estimated by using the IOTA logistic regression models LR1 and LR2. Twelve variables were used for the LR1 calculation: (1) personal history of ovarian cancer (yes = 1, no = 0); (2) current use of hormonal therapy (yes = 1, no = 0); (3) age of the patient (years); (4) maximum diameter of lesion (mm); (5) (12) , as described in the original IOTA study. The probability y is dichotomized at a score of 0.1 to give a predictive diagnosis of cancer.
LR2 was calculated based on six of the above variables: (3), (6) , (7), (9), (10) and (11) . The formula to determine the probability of malignancy was: y = 1/(1 + exp -z ), where z = -5.3718 + 0.0354 (3) + 1.6159 (6) + 1.1768 (7) + 0.0697 (9) + 0.9586 (10) − 2.9486 (11) and, as with LR1, the probability y is dichotomized at a score of 0.1 to give a predictive diagnosis of cancer.
The Level-II operator recorded IOTA assessments in the research file and these assessments were not available to the clinicians who made decisions about the patients' care plans. In cases of multiple lesions, those that were more likely to be malignant according to the IOTA model score were included in the analysis, as the diagnosis of malignancy in one lesion supersedes the diagnosis of any coexisting benign lesions. Following examination by the Level-II operator, women with an adnexal tumor were re-examined independently by an expert ultrasound operator (D.J.), who used subjective pattern recognition to determine the nature of the adnexal tumor. Women with suspected ovarian cancer following the expert examination were referred to our gynecological oncology team for further management. Women with presumed benign lesions were offered the choice between conservative management and surgery, taking into account their clinical symptoms and personal preference.
Women who opted for conservative management were offered regular follow-up ultrasound scans, starting with 6-month intervals, for a minimum of 12 months. Women who became symptomatic during follow-up and those who requested an intervention were offered surgery. For those who remained asymptomatic, follow-up ultrasound findings were compared with the initial diagnosis. Surgery was offered to all women for whom tumor classification was changed from benign to malignant on any of the follow-up ultrasound scans. Only when data collection was complete at the end of the study were the IOTA-LR1 and -LR2 calculations of the risk of malignancy performed and included in the data collection sheets. Histopathology was the primary reference standard used. Tumors were classified according to the World Health Organization guidelines, and malignancies were staged according to the International Federation of Gynecology and Obstetrics criteria 11, 12 . For the women for whom surgery was not required, an ultrasound scan at 12 months or more after the primary scan confirming the initial diagnosis of a benign lesion was used as the second reference standard.
The local research and development department determined that formal ethical assessment and approval were not required, as the steps in the conduct of the study were routine practice in the unit. This includes morphological analysis of the tumors using the IOTA examination technique, measurement technique and terminology for the assessment of adnexal masses, which are also a part of our standard clinical practice. In addition to this, therapeutic decisions were not based on the IOTA model scores.
Statistical analysis
The sample size for this study was determined using Harrell's recommendation that a validation dataset should contain at least 100 'events', i.e. borderline or malignant tumors 13 . Our validation dataset has 137 events; it therefore satisfies this requirement.
Initially, the data were analyzed assuming that both reference tests had perfect (100%) sensitivity and specificity. Sensitivity, specificity and overall accuracy of the three diagnostic tests (LR1, LR2 and pattern recognition) were calculated under this assumption and presented with exact 95% CIs. Formal comparisons across different index tests were made using McNemar's test; the exact version of this test was used when necessary. These analyses were performed using the software package Stata 14.0 (StataCorp, College Station, TX, USA).
A secondary analysis was performed using a Bayesian approach similar to that of de Groot et al.
14 . This analysis was performed to reduce bias that may occur if the results of the alternative reference standard (follow-up ultrasound) are treated identically to the results from the preferred reference standard (histology), when the former may be of lower quality. In detail, we created a probabilistic model that relates the underlying (unknown) status of the patient to the results of the corresponding reference test. This model assumes that the choice of reference test (histology or follow-up ultrasound) was related to the underlying status of the patient (that is, patients with cancer were more likely to be assessed using histology). In addition, we assumed that the histology results were always correct, whereas the ultrasound results were imperfect. Our prior belief was that the sensitivity and specificity of ultrasound were both probably close to 90% and almost certainly within the range 80-100%. Low information priors were used for all other parameters. The software application OpenBUGS (www.openbugs.net) was used to estimate (posterior) distributions for the model parameters, including patient status and sensitivities and specificities of follow-up ultrasound and the three diagnostic tests 15 . All results are presented as medians with 95% credible intervals. To check the robustness of our results, additional analyses were run in which the prior beliefs for ultrasound performance were changed to reflect worse performance.
RESULTS
A total of 555 consecutive women attended for ultrasound assessment during the study period. Eleven women were pregnant and therefore excluded from the data analysis. A flowchart showing eligibility of women for the study and a summary of their management is shown in Figure 1 . Three hundred and forty-two of the remaining 544 (62.9%) women had surgery after their first or a subsequent ultrasound scan, while 147/544 (27.0%) were managed conservatively (Table 1) . Of the initially included women, 41/544 (7.5%) were lost to follow-up, 13 died soon after the diagnosis of adnexal tumor was made, and one received chemotherapy as the primary treatment for presumed metastatic bowel cancer. Among the 13 women who died, five had a non-ovarian malignancy (esophageal (n = 2), pancreatic, cervical or endometrial), four had non-malignant medical conditions (amyloidosis, chronic renal failure and bronchiectasis, dementia with urinary sepsis or alcohol-induced liver failure) and four had suspected ovarian malignancies. The patients' mean age was 50 years (range, 16-91 years), and 237/544 were postmenopausal.
After excluding the 55 (10.1%) women who had neither reference test, the final diagnosis of a malignant tumor was made in 137/489 (28.0%) women and benign tumors were diagnosed in the remaining 352 (72.0%). A histological diagnosis was available for 342 women ( Table 2 ). The The most common indications for surgery in the 342 women for whom a histological diagnosis was available were suspected ovarian cancer (n = 152 (44.4%)) and pelvic pain (n = 75 (21.9%)). Other indications were the woman's choice (n = 62 (18.1%)), part of subfertility or urological surgery (n = 35 (10.2%)) and other reasons (n = 18 (5.3%)), such as pressure symptoms, UK Collaborative Trial of Ovarian Cancer Screening positive, prophylactic surgery or change in the appearance of the tumor on follow-up. In the 147 women managed expectantly, only eight tumors increased in size during follow-up, while the remaining 139 (94.6%) stayed the same size, decreased in size or resolved completely (Table 3 ). In these eight women, the cyst increased in size by between 21% and 94%, but none of the women had surgery for that reason. In women managed expectantly, the median time for their follow-up ultrasound scan was 14.5 months (range, 12-68 months). *Cystadenoma (n = 43), cystadenofibroma (n = 14). †Functional (n = 3), cystadenofibroma (n = 1), fibroma (n = 1). Using pattern recognition as the primary diagnostic test, 148 women were diagnosed with cancer. Management of the women according to the predicted nature of the pelvic tumor is shown in Table 4 . The predicted diagnoses of the nature of the adnexal tumors at the initial visit using pattern recognition, LR1 and LR2 are shown in Table 5 . There were significant differences between pattern recognition and LR1 in classifying ovarian tumors, which was mainly due to discordant results in women with benign lesions ( Table 6 ). Assuming that the rate of intervention would be identical in women diagnosed with cancer and those diagnosed with benign disease, regardless of the diagnostic method used, there would also be a significant increase in the number of women having surgery for presumed malignancy if IOTA models were used instead of pattern recognition to assess women for the need for intervention (P < 0.0001). This is because the false-positive rate for LR1/LR2 was significantly higher than that for pattern recognition. The overall intervention rates, including both benign and malignant lesions for pattern recognition, LR1 and LR2, however, would not be significantly different (P > 0.05) ( Table 5 ). Data are given as n (%). All data are n. P < 0.0001 for benign tumors; P = 0.13 (exact) for malignant tumors.
Ten patients had surgery after completing 12 months of follow-up, which enabled us to make a comparison of the two reference standards. One of these women had discordant results for histology and the follow-up ultrasound scan. The results, however, suggest a good level of agreement between histology and follow-up visit strategy. The woman with the discordant results had surgery because her tumor had changed morphologically. The histology result, however, was benign polypoid endometriosis.
Primary analysis was performed assuming that both reference tests (histology and follow-up ultrasound scan) had perfect accuracy (Table 7) . This showed that LR1, LR2 and pattern recognition had high sensitivities, but there were significant differences in the specificities for the diagnosis of ovarian cancer between pattern recognition and the IOTA models when tests were carried out at the initial visit. If differing accuracy for histology (100%) and follow-up ultrasound scan (90%) was assumed, the results were similar to those found when both reference tests were assumed to be 100% accurate (Table 8) .
Eight women with cancer (borderline (n = 5) or invasive (n = 3)) were misdiagnosed with benign disease using pattern recognition (8/137 (5.8% (95% CI, 2.6-11.2%))). All three invasive malignancies were Stage I, with two dermoid tumors with early malignant transformation within and one seromucinous adenocarcinoma. This caused delayed intervention in only one woman, who was diagnosed eventually with a borderline tumor. Using LR1, there would have been four false-negative cancer diagnoses (borderline (n = 2) or invasive (n = 2)) (2.9% (95% CI, 0.8-7.3%); P = 0.13 when compared with pattern recognition) compared with seven (borderline (n = 3) or invasive (n = 4)) (5.1% (95% CI, 2.1-10.2%)) using LR2 (P = 1.0 when compared with pattern recognition); neither difference was statistically significant. The tumors missed by LR1/LR2 were those missed by pattern recognition, except for one metastatic tumor detected by pattern recognition and missed by LR1.
DISCUSSION
This study has shown that the accuracy of LR1/LR2 for the diagnosis of ovarian cancer in the outpatient setting is similar to that found in previous studies that were carried out preoperatively. However, if LR1/LR2 had been used as the primary diagnostic test to guide management decisions, rather than pattern recognition, a significantly higher proportion of women would have been referred for treatment by gynecological oncologists because of suspected ovarian cancer.
In previous original and subsequent validation studies, the IOTA logistic regression models provided an accurate diagnosis of ovarian cancer, by both expert and non-expert operators 1, 4, [16] [17] [18] . The models, however, had always been used in a population of women who had all undergone surgery. In view of this, the results could have been affected by selection bias, and they cannot be extrapolated to low-risk populations in which the majority of women do not require surgical intervention. The results of previous studies can therefore be used only to help to select a surgeon (general or oncological) to perform the operation or the route of the surgery (laparoscopic or open) 19 . A more relevant question in clinical practice, however, is whether surgery is required at all for women whose symptoms, fertility or wishes do not indicate that surgery is required.
A difficulty in conducting a study on a population of women with adnexal tumors who are managed conservatively is the lack of agreement on the reference standard by which the nature of the lesion is defined. In women with presumed benign lesions, the only way to rule out ovarian cancer in the absence of histological diagnosis is by arranging follow-up visits for a certain length of time. The natural history of ovarian cancer is unknown and decisions on the length and frequency of follow-up visits are pragmatic and based on a consensus of opinions, rather than on science. Most ovarian cancer screening projects have adopted a policy of 6-monthly or annual visits for women with normal ultrasound findings, which is deemed to be sufficiently frequent to detect early disease before it spreads beyond the ovaries 20 . All the women in our study had detectable lesions at the time of the initial scan. We therefore postulate that, under such circumstances, 12-month follow-up should be long enough to detect changes in the appearance and size of adnexal tumors that would be suggestive of their malignant nature. Absence of these changes is how the second reference standard indicates a benign lesion.
During follow-up, it is possible that some women could develop new abnormalities. This could be classified erroneously as a prior misdiagnosis rather than correctly as a new disease. However, in some women it should be possible to identify two separate lesions, which may overcome this limitation in a proportion of cases.
All the women in this study were assessed using at least one of the two reference standards: histology and/or a follow-up ultrasound scan at or after 12 months. This helped us to reduce the incomplete verification bias of including only surgical patients. Bias may still arise, however, if the results of the alternative reference standard (follow-up ultrasound scan) are treated identically to the results from the preferred reference standard (histology), when they may not be identical. This is because the two reference standards may be of different quality, and it is possible that follow-up ultrasound scans would be less than 100% accurate when compared with histology. This information was taken into account when performing the statistical analysis in this study; the results were not different when the presumed accuracy of ultrasound follow-up was reduced to 90% 14 . Our results showed that, in this population with a malignancy rate of 28.0%, the LR1 and LR2 models have high sensitivity and moderate specificity for diagnosing ovarian cancer. The specificity of LR1 and LR2 models was significantly lower than that of pattern recognition (P < 0.0001), while the sensitivity was not significantly different (P = 0.13 for LR1). This relatively high false-positive rate of LR1 would theoretically result in 62% more women being treated for potential ovarian cancer. However, the four women with a false-negative diagnosis of ovarian cancer (one invasive epithelial and three borderline) would have received treatment earlier.
A strength of this study is that it assessed and corrected for the potential bias associated with analyzing only the women who had surgery; it is the first study on LR1/LR2 to do this.
The study also has some limitations. The overall intervention rate was relatively high, which reflects the nature of work in a large clinical center. Many women are referred following the diagnosis of an adnexal cyst for primary or community care. They often have larger lesions and are advised by their general practitioners that surgery is required, even if the lesions are considered to be benign. The diagnostic strategy described in this study is appropriate for specialists making decisions about surgery. Further work is required to assess the suitability of the IOTA models to assist general practitioners and Level-I operators in deciding who should be referred to specialist centers for further assessment.
In addition, 10% of women who were diagnosed with benign tumors on pattern recognition did not complete follow-up. There were no missed malignancies in the 147 women with complete follow-up data who were also managed expectantly. In view of this, it is unlikely that the performance of the IOTA models and that of pattern recognition would have been significantly different had all the women completed the study.
Further studies are required to assess the performance of the IOTA models as used by Level-II sonographers receiving direct referrals from primary care and reproductive healthcare physicians, circumstances in which the risk of ovarian cancer and the proportion of complex tumors difficult to classify on ultrasound would be lower than in our population.
